Followers | 176 |
Posts | 29714 |
Boards Moderated | 1 |
Alias Born | 03/28/2007 |
Thursday, March 27, 2008 6:17:02 PM
Company Achieves Second Quarter Records in Sales, Orders, Backlog, Profits and Cash Flow
DAYTON, Ohio, March 26 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) today reported diluted net earnings per share (DEPS) of $0.47 for its fiscal second quarter ended February 29, 2008, more than double the $0.23 of DEPS reported in the prior year comparable period. The year-over-year increase in DEPS was attributed to higher sales, an improved cost structure, and a lower tax rate. Current year quarter results include approximately $0.02 per share of benefit from the sale of a facility, as well as approximately $0.01 per share of benefit from the favorable resolution of a tax matter. All reported results reflect the Company's recent 2-for-1 stock split of its common shares.
Robbins & Myers reported second quarter 2008 sales of $185 million, $22 million or 14% higher than in the prior year comparable period. Orders were $216 million in the second quarter of 2008, $33 million or 18% higher than in the prior year second quarter. Excluding the impact from acquired and disposed product lines and currency translation, sales increased 7% and orders increased 8%. The Company ended the quarter with backlog of $264 million.
'Market conditions remain favorable in our key end markets with notable sales growth in global energy and chemical sectors,' said Peter C. Wallace, President and Chief Executive Officer of Robbins & Myers, Inc. 'We continue to improve our capabilities to meet rising customer demand, not only by making targeted investments in capital and people, but also through greater integration of our operations and process improvements associated with our lean enterprise initiatives. These improved capabilities are also helping to improve our profitability and cash flow.'
The Company achieved $26 million of earnings before interest, taxes and minority interest (EBIT) in the second quarter of 2008, 66% higher than the comparable prior year quarter. The EBIT margin of 14.2% in the quarter represents an increase of 450 basis points. Excluding special items, which included a facility sale gain in the second quarter of 2008 and restructuring costs in the second quarter of 2007, adjusted EBIT margins increased 270 basis points to 13.6% due largely to increased sales and restructuring activities completed in the prior year. Trailing twelve-month EBITDA has grown to $123 million, 60% higher than the year-ago comparable figure.
'Robbins & Myers' strong profitability in the quarter was amplified by improvements in working capital, enabling us to achieve $26 million of cash flow from operating activities,' said Mr. Wallace. 'During the quarter we also sold a facility related to a previously-disposed product line, and we continue to look for other opportunities to reduce the complexity and capital- intensity of our business. We ended the quarter with $131 million of cash, substantially higher than our debt levels. The Company is well-positioned for the remainder of fiscal 2008.'
The Company announced that it is increasing its full year 2008 DEPS guidance from $1.78-$1.88 to $1.82-$1.92. The Company also established third quarter 2008 DEPS guidance of $0.42-$0.47, as compared with actual results of $0.39 in the third quarter of 2007. On March 31, 2008, the escrow period related to the Company's fiscal 2006 sale of certain product lines will conclude, as will certain contingency obligations, which could result in a one-time benefit to third quarter 2008 earnings and cash flow. The Company's guidance excludes any potential impact from this matter.
Second Quarter Results by Segment
All comparisons are made against the comparable year-ago quarterly period unless otherwise stated.
The Company's Fluid Management segment reported second quarter sales of $77 million, a 12% increase, and orders of $74 million, a 7% decrease. Excluding currency exchange rate effects, sales increased 8% and orders declined 11%. The prior year quarter included an $8 million international order for annual requirements of a single customer which did not repeat in the current year. EBIT grew 22% to $21 million, and EBIT margins expanded 220 basis points to 27.4%.
The Process Solutions segment reported sales of $75 million in the second quarter, a 19% increase, and orders of $94 million, a 35% increase. Excluding the effects of currency exchange rates and an acquisition, sales increased 7% and orders climbed 22%, primarily on continued strength in global chemical markets. The segment earned $7 million of EBIT in the second quarter, and EBIT margins improved 260 basis points to 10.0%. In January 2008, the Company's 51%-owned Indian subsidiary acquired Mavag AG, a small manufacturer of processing equipment for the pharmaceutical market.
The Romaco segment reported that sales grew 7% to $33 million in the second quarter, and orders were up 43% to $48 million. Excluding the impact from a disposed product line and currency exchange rates, sales increased 5% and orders increased 26% as a result of several recent large project wins for packaging and secondary processing applications. Excluding facility sale gains and restructuring costs, Romaco reported that adjusted EBIT margins jumped 440 basis points to 3.0% as a result of increased sales and restructuring activities completed in the prior year.
Conference Call to Be Held at 2:00 PM (EDT) Thursday, March 27, 2008
A conference call to discuss these results has been scheduled for 2:00 p.m. EDT on Thursday, March 27, 2008, which can be accessed at www.robn.com or by dialing (866) 383-8009 (US/Canada) or +1-617-597-5342, using conference ID #84383242. Replays of the call can be accessed by dialing +1-888-286-8010 (U.S./Canada) or +1-617-801-6888, both using replay ID #30887500.
About Robbins & Myers
Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.
Information on oil Click here: #board-6609
Recent RBN News
- Robinson PLC Holding(s) in Company • RNS Regulatory News • 04/19/2024 01:45:01 PM
- Robinson PLC Final Results • RNS Regulatory News • 03/22/2024 07:00:06 AM
- GetBusy hails integration into Ultratax • Alliance News • 01/18/2024 02:31:54 PM
- Robinson PLC Trading Statement • UK Regulatory • 01/18/2024 07:00:00 AM
- Robinson hit by Storm Babet, Altona loss widens • Alliance News • 10/24/2023 06:21:57 PM
- Robinson PLC Impact of Storm Babet • UK Regulatory • 10/24/2023 01:35:00 PM
- Robinson profit to fall, revenue to grow in 2023 — finnCap • Alliance News • 08/17/2023 11:00:48 AM
- Robinson maintains half-year dividend despite swing to loss • Alliance News • 08/17/2023 09:10:45 AM
- Robinson PLC Interim Results • UK Regulatory • 08/17/2023 06:00:00 AM
- Robinson makes gain on property sale; reaches pension accord • Alliance News • 08/14/2023 09:07:57 AM
- Robinson PLC Company Update and Notice of Results • UK Regulatory • 08/14/2023 06:00:00 AM
- Robinson PLC Result of AGM • UK Regulatory • 06/23/2023 06:00:00 AM
- Robinson says annual profit to be in line with guidance • Alliance News • 06/22/2023 09:25:41 AM
- Robinson PLC AGM Statement • UK Regulatory • 06/22/2023 06:00:00 AM
- Robinson sells part of Walton Works property to Peppermint Grove • Alliance News • 05/31/2023 12:37:14 PM
- Robinson PLC Sale of Property • UK Regulatory • 05/31/2023 06:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM